Xenon Pharmaceuticals Inc. Quarterly Marketable Securities, Current in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Xenon Pharmaceuticals Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2013 to Q2 2024.
  • Xenon Pharmaceuticals Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $585M, a 23.1% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $585M +$110M +23.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $641M +$183M +40% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $489M -$45.4M -8.49% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $427M -$108M -20.1% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $475M +$56.8M +13.6% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $458M +$36.1M +8.57% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $535M +$159M +42.2% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $535M +$373M +230% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $418M +$241M +136% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $421M +$235M +126% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $376M +$244M +185% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $162M -$14M -7.97% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $178M +$19M +12% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $187M +$17.6M +10.4% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $132M +$15.4M +13.2% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $176M +$119M +209% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $159M +$93.8M +145% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $169M +$111M +190% Mar 31, 2020 10-Q/A 2020-05-26
Q4 2019 $117M +$65.1M +126% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $56.9M +$17.8M +45.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $64.7M +$48.9M +309% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $58.2M +$40.4M +226% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $51.6M +$28.4M +122% Dec 31, 2018 10-K 2020-03-09
Q3 2018 $39.2M +$10.1M +34.7% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $15.8M -$12.8M -44.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $17.9M -$20M -52.8% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $23.2M -$23.9M -50.7% Dec 31, 2017 10-K 2019-03-06
Q3 2017 $29.1M +$13.7M +89.4% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $28.6M +$13.1M +84.2% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $37.9M Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $47.1M Dec 31, 2016 10-K 2018-03-07
Q3 2016 $15.4M Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $15.5M +$6.17M +66% Jun 30, 2016 10-Q 2016-08-03
Q2 2015 $9.35M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $9.46M Mar 31, 2015 10-Q/A 2015-08-13
Q4 2014 $12M +$689K +6.08% Dec 31, 2014 10-K 2016-03-08
Q3 2014 $14.2M Sep 30, 2014 10-Q 2014-12-15
Q4 2013 $11.3M Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.